Tirzepatide, a groundbreaking drug, represents a significant innovation in the approach of type 2 diabetes mellitus and, more recently, obesity. This dual compound acts upon two crucial hormones: incretin hormone and GIP. Unlike traditional diabetes drugs, Tirzepatide encourages not only insulin release when glucose levels are elevated but also red